SCHEMBL24475679

SCHEMBL24475679

c1cnc2c(c1)ccc1ccc(-c3ccc(-c4ccc5ccc(-c6ccc7nc(-c8ccc9c%10ccccc%10c%10ccccc%10c9c8)ccc7c6)cc5n4)cc3)nc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.42
RAB9A P51151 6/20 0.42
POLB P06746 1/20 0.42
LMNA P02545 3/20 0.40
CYP3A4 P08684 4/20 0.40
AR P10275 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
TOP1 P11387 5/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 5/20 0.38
SMN1; SMN2 Q16637 5/20 0.38
ALDH1A1 P00352 4/20 0.38
MAPT P10636 3/20 0.38
GMNN O75496 2/20 0.38
TP53 P04637 2/20 0.38
THPO P40225 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23016260 0.96 NPC1 (0.45) NPC1RAB9APOLBLMNACYP3A4
SCHEMBL24475480 0.95 TOP1 (0.43) NPC1RAB9ALMNACYP3A4AR
SCHEMBL23016378 0.94 NPC1 (0.45) NPC1RAB9APOLBLMNACYP3A4
SCHEMBL18904440 0.94 LMNA (0.45) NPC1RAB9APOLBLMNACYP3A4
SCHEMBL23016131 0.92 NPC1 (0.43) NPC1RAB9APOLBLMNACYP3A4
SCHEMBL24475519 0.91 TOP1 (0.39) NPC1RAB9APOLBLMNACYP3A4
SCHEMBL23016217 0.91 NPC1 (0.42) NPC1RAB9APOLBLMNACYP3A4
SCHEMBL22282089 0.90 NPC1 (0.46) NPC1RAB9APOLBLMNACYP3A4
SCHEMBL24475380 0.90 TOP1 (0.40) NPC1RAB9APOLBLMNACYP3A4
SCHEMBL22282130 0.90 NPC1 (0.41) NPC1RAB9APOLBLMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220173329-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE LT MATERIALS CO., LTD. (KR) 2022-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220173329-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE OXER1, OCIAD1, OR10J3 NPC1 953/4885RAB9A 2499/4885POLB 3997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.